Brief Article
Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 14, 2010; 16(42): 5359-5366
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5359
Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand
Paramee Thongsuksai, Pleumjit Boonyaphiphat, Puttisak Puttawibul, Wanna Sudhikaran
Paramee Thongsuksai, Pleumjit Boonyaphiphat, Wanna Sudhikaran, Department of Pathology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand
Puttisak Puttawibul, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand
Author contributions: Thongsuksai P designed the research, analyzed the data, and wrote the paper; Boonyaphiphat P and Sudhikaran W contributed to sample collection and performed the laboratory work; Puttawibul P contributed to sample collection and provided clinical data.
Supported by The Annual Research Fund of the National Research Council of Thailand
Correspondence to: Paramee Thongsuksai, MD, Associate Professor of Pathology, Department of Pathology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand. tparamee@gmail.com
Telephone: +66-74-451593 Fax: +66-74-212908
Received: July 12, 2010
Revised: August 21, 2010
Accepted: August 28, 2010
Published online: November 14, 2010
Abstract

AIM: To investigate p53 mutations in esophageal cancer in a high-risk population, and correlate them with smoking, alcohol consumption and betel chewing.

METHODS: One hundred and sixty-five tumor samples of esophageal squamous cell carcinoma (ESCC) obtained from a university hospital in Songkhla province, Southern Thailand were investigated for p53 mutations in exons 5-8, using polymerase chain reaction-single strand conformation polymorphism analysis, followed by direct sequencing. A polymerase chain reaction-restriction fragment length polymorphism (RFLP) assay was additionally used to confirm possible germline mutation in intron 6. A history of risk habits was obtained by interviews. The association between risk habits and mutation frequency was evaluated using the χ2 test.

RESULTS: The studied specimens were from 139 male and 26 female patients with ESCC, treated at Songklanagarind Hospital. Most of the patients were smokers (86.7%) and alcohol consumers (72.73%), and 38.3% were betel chewers. Forty-three mutations of the p53 gene were detected in 25.5% (42/165) of tumor samples. Mutations were most commonly found in exon 5 (25.6%) and exon 8 (25.6%). Mutations in the hot-spot codon 248 were found in four cases (9.3% of all mutations). G:C→C:G (30.23%), G:C→A:T (27.90%) and G:C→T:A (16.28%) were the prevalent spectra of mutations. Unexpectedly, among 10 intronic mutations, eight cases harbored a similar mutation: G→C substitution in intron 6 (nucleotide 12759, GenBank NC_000017). These were additionally confirmed by the RFLP technique. Similar mutations were also detected in their matched blood samples using RFLP and direct sequencing, which suggested germline mutations. There was no significant correlation between risk habits and p53 mutation frequency.

CONCLUSION: A proportion of Thai ESCC patients harbored specific intronic p53 mutations, which might be germline mutations. Further studies are needed to explore this novel finding.

Keywords: Esophageal cancer; Squamous cell carcinoma; p53 gene; Germline mutation; Mutation; Intron